Calendar

Cloudflare’s reported Q2 2026 revenue growth and a $736.8M Q3 revenue consensus provide a credible business backdrop, but the stock fell sharply into the event: it lost roughly 15.5% from Oct. 26 to Oct. 30, including a high-volume down day. Required positive tape and estimate-upside signals are not supported.

ABNB has a small positive whisper-versus-consensus gap and recent company guidance describes strong revenue growth, but the guidance midpoint is slightly below the checked revenue consensus. The stock fell about 4.4% over five sessions, had no close above the 0.75 close-location threshold in the latest three sessions, and no confirmed 1.5x volume session; it does not qualify despite a supportive XLY tape.

EOG has upward EPS estimate revisions, a credible Q3 consensus, and a strong Oct. 30 close, but available checks did not establish positive revenue revisions or a recent >1.5x-volume accumulation day. The company has scheduled its Q3 results for Nov. 5 after close; its IR page separately lists a Nov. 6 results call.

Lumentum's September-quarter EPS estimate rose from $4.21 to $4.22 over the last month, and its prior company guidance midpoint for $1.25B revenue is in line with reported consensus; management cited accelerating AI-driven optical demand and the stock advanced sharply over the preceding five sessions. However, the late-week reversal and lack of a verified normal-volume comparator temper the setup, while valuation and execution risks remain material.

Simon has positive, though non-uniform, estimate momentum: checked consensus showed EPS up 1.74% and revenue up 3.69% over three months, and its latest reported quarter showed 96.0% occupancy, higher retailer sales, and raised full-year FFO guidance. The stock gained about 2.4% over five sessions and closed near the top of its Oct 30 range, but a normal-volume comparison was unavailable and its recent earnings history is uneven.

DVN has positive near-term estimate revisions, rising revenue expectations, four recent EPS beats per Zacks, and an official Nov. 5 reporting date; the stock also strengthened into the event. However, earnings-whisper EPS is below some consensus figures and the shares lagged the energy sector over the past month, while commodity exposure and transaction execution leave meaningful uncertainty.

Earnings Whispers reports a $1.48 whisper against $1.39 consensus, while the prior quarter had strong reported growth; however, no reliable pre-event revenue-revision, verified close-location, or volume-accumulation evidence was found for this screen, and the supplied latest close does not establish recent strength. The positive whisper alone is insufficient for qualification.

ED's reported date and consensus figures were available, and the recent close rose with XLU supportive; Con Edison had reaffirmed its 2026 adjusted EPS guidance. But no positive EPS revision, ESP, whisper, or revenue-upside signal was verified, and none of the last three checked sessions closed in the upper quarter of its range.

A pre-event Zacks article says the estimate-revision combination points toward a likely EPS beat, and recent annualized recovery expectations offer a possible cyclical catalyst. However, exact revision and current-quarter revenue consensus/upside evidence was not verifiable in the checked results, while Oct. 30 brought a high-volume 4.66% selloff and a weak close; it fails the required tape confirmation.

Live Nation has strong operating indicators ahead of the report: the latest available filing said 2026 event ticket sales were pacing 11% higher and deferred revenue reached a second-quarter record, while the stock recovered into Oct. 30 on a large-volume up day. But current-quarter revenue consensus estimates varied across checked providers and no positive EPS revision/ESP/whisper was verified; score remains below the required threshold.

The supplied Nov. 5 date conflicts with checked earnings sources: Earnings Whispers and MarketBeat indicate Nov. 4, while another estimate page shows Nov. 5 and cautions the date may move. Consensus estimates exist, but no positive revisions or required tape confirmation were established; reject on unconfirmed event date and incomplete signals.

MRNA has a modestly favorable EPS revision snapshot and a recent high-volume rebound, but the checked calendar sources describe Nov. 6 as estimated rather than company-confirmed, and no positive revenue revision or upside indicator was verified. The Oct. 22 melanoma-trial data leak coincided with a 17.57% drop and unusually high volume, leaving a volatile, event-driven tape.

Record Q2 fundraising and 20% fee-related-earnings growth, alongside a rising recent share price and several analyst target cuts, create a constructive but mixed backdrop. The checked sources support EPS and revenue consensus, but do not establish positive estimate revisions or an upside surprise signal; recent volume also falls short of a verified accumulation trigger.

Humana's primary IR estimate table showed near-flat Q3 EPS revisions and a credible consensus source provides EPS and revenue estimates, but the stock weakened into the event and underperformed the rising XLV. Medical-cost and Medicare policy uncertainty remain material, while recent tape did not confirm accumulation.

Vistra has a company-confirmed Nov. 6 report date and a strongly positive 30-day Q3 EPS revision, alongside long-term power-demand catalysts. However, shares declined about 5.4% from Oct. 26 through Oct. 30, recent closes were weak in their daily ranges, and the latest quarter missed consensus materially. Positive revisions alone do not offset the poor pre-event tape and limited recent execution evidence.

The post-release reaction was negative: DX closed October 19 at $10.56, down 3.39% from the prior close, consistent with the packet anchor; this does not isolate earnings from broader trading effects. [Investing.com price history](https://www.investing.com/equities/dynex-capital-inc-historical-data) A post-print JonesTrading target cut is available, but a full set of forward-estimate revisions is not. The deterministic prior remains negative and the Q3 book-value loss materially strengthens the cautious case despite management's stated investment opportunity.

The company release is constructive on earnings and balance-sheet growth, but the consensus beat is modest and credit costs rose. One third-party report described an immediate 0.6% post-release share dip; a reliable October 20 closing reaction and evidence that any move held were not yet available. No verified post-print target or estimate revisions were found, so their absence is not a positive signal. Social, options, short-interest and employee sentiment were not assessed. [#SEC-8K-2026-10-19] [Immediate-reaction report](https://www.investing.com/news/earnings/wintrust-financial-posts-q3-beat-but-shares-dip-as-net-chargeoffs-rise-93CH-4958354)

The company-confirmed EPS beat improves the prior monitoring thesis, consistent with the deterministic prior’s positive direction and elevated thesis-change score. Core margin and expense trends temper that improvement. No reliable regular-session post-release price reaction or post-print analyst revision was verified at this early T+1 checkpoint; the packet’s analyst target has unknown freshness. Sentiment metrics other than headline buzz are unavailable, so their zero values are placeholders, not measured neutral readings.

The third-quarter beat is offset by below-consensus fourth-quarter guidance. Investing.com reported a roughly 5% after-hours decline on October 19 and a smaller pre-open decline on October 20; neither establishes the regular-session closing reaction. [Investing.com after-hours](https://www.investing.com/news/stock-market-news/why-is-crown-stock-sliding-afterhours-today-93CH-4958380) [Investing.com pre-open](https://www.investing.com/news/stock-market-news/why-is-crown-stock-sliding-today-93CH-4959167) Post-print analyst revisions and a verified call transcript were unavailable at this cutoff. The zero sentiment fields are unmeasured placeholders, not neutral readings.

This is a cautious T+1 monitoring update, not a confirmed post-earnings reassessment: targeted checks found no October 19 company release or filing. Consensus surprise, analyst revisions and a result-linked market reaction are unavailable. The packet's $2.22 October 19 price is an anchor, not evidence of a post-release move. Sentiment fields set to zero denote unavailable measurements, not neutral readings.

News tone is mixed-to-negative after the revenue miss despite solid underwriting. WRB closed October 19 at the packet's $74.08 anchor and was reported near $72.83 after hours; that is not a confirmed October 20 regular-session move. [Post-release reaction](https://www.investing.com/news/transcripts/earnings-call-transcript-w-r-berkley-tops-eps-in-q3-2026-but-misses-revenue-93CH-4958434) One post-print target increase was located, but its Underweight rating remained; broader analyst estimate revisions are not yet established at this early T+1 checkpoint. [Wells Fargo reaction](https://www.investing.com/news/analyst-ratings/wells-fargo-raises-wr-berkley-stock-price-target-on-loss-ratio-beat-93CH-4959481) Social, options, short-interest, and employee measures were unavailable in the packet; zero entries above denote unavailable data, not neutral readings.

Home Depot Has Raised Its Dividend for 17 Consecutive Years and Reports Earnings Aug . 18 . Is It the Smarter Dow Stock to Buy Over Walmart ?